Peter Doyle | CEO and Co-founder
biosimulytics
Accelerating drug development through in silico crystal structure prediction.
Appearances:
BioTechX USA Day 2 @ 11:45
Early Polymorph Prediction from Preclinical: reducing risk and accelerating time-to-market through fast and cost-effective in silico screening methods
last published: 29/Aug/25 15:56 GMT
Get involved at BioTechX USA
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events